Journal of Global Pharma Technology
Volume 09 Issue 08

Vitronectin, Integrin Vitronectin Receptor Other Biochemical Markers to Assess the Development of Liver Cirrhosis

Huda Jaber Waheed (Unknown)



Article Info

Publish Date
15 Dec 2017

Abstract

Aim of study: To evaluate some fibrosis markers such as vitronectin, serum vitronectin receptor (VNR) and the amino terminal propeptide of type III procollagen (P-III-P) in the sera of liver cirrhosis patients and to monitor the behavior of these markers in disease progression. Material and Methods: About (60) volunteer participated in current study; 30 patients and 30 patients. The patients were divided according to severity of the disease by Child-Pugh Score to three classes: (10) patients class A, (10) class B patients and (10) class C. Procollagen III peptide, serum vitronectin and vitronectin receptor were measured in serum by ELISA. Results: A Significant increases were found in serum vitronectin, receptor and sP-III-P in all patients' sub-groups when compared to control. VNR seems to detect early liver cirrhosis and distinguish between patients (A and B classes) and advanced disease with cirrhosis. Conclusion: According to our data, the area under curve of serum VNR is greater than vitronectin and Sp-III-P so it can be act as a marker of liver cirrhosis and also could be used to monitor the severity of disease.  

Copyrights © 2017






Journal Info

Abbrev

jgpt

Publisher

Subject

Medicine & Pharmacology

Description

ournal of Global Pharma Technology is a monthly, open access, Peer review journal of Pharmacy published by JGPT Journal publishes peer-reviewed original research papers, case reports and systematic reviews. The journal allows free access to its contents, which is likely to attract more readers and ...